UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antibodies as therapeutic agents: vive la renaissance

Expert opinion on biological therapy, 2003-10, Vol.3 (7), p.1133-1152

2003

Volltextzugriff (PDF)

An enthesitis based model for the pathogenesis of spondyloarthropathy. additive effects of microbial adjuvant and biomechanical factors at disease sites

Journal of rheumatology, 2001-10, Vol.28 (10), p.2155

2001

Volltextzugriff (PDF)

The role of therapeutic antibodies in drug discovery

Biochemical Society transactions, 2003-04, Vol.31 (2), p.433-436

2003

Volltextzugriff (PDF)

Dendritic cells: Immunological sentinels with a central role in health and disease

Immunology and cell biology, 2000-04, Vol.78 (2), p.91-102

2000

Volltextzugriff (PDF)

The BCL11AXL transcription factor: its distribution in normal and malignant tissues and use as a marker for plasmacytoid dendritic cells

Leukemia, 2006-08, Vol.20 (8), p.1439-1441

2006

Volltextzugriff (PDF)

CD70 (TNFSF7) is expressed at high prevalence in renal cell carcinomas and is rapidly internalised on antibody binding

British journal of cancer, 2006-08, Vol.95 (3), p.298-306

2006

Volltextzugriff (PDF)

Coxsackie and adenovirus receptor (CAR)-dependent and major histocompatibility complex (MHC) class I-independent uptake of recombinant adenoviruses into human tumour cells

Gene therapy, 1999-09, Vol.6 (9), p.1512-1519

1999

Volltextzugriff (PDF)

Coxsackie B and adenovirus receptor, integrin and major histocompatibility complex class I expression in human prostate cancer cell lines: implications for gene therapy strategies

Prostate cancer and prostatic diseases, 2003-03, Vol.6 (1), p.6-11

2003

Volltextzugriff (PDF)

Engineered expression of the Coxsackie B and adenovirus receptor (CAR) in human dendritic cells enhances recombinant adenovirus-mediated gene transfer

Journal of immunological methods, 2002, Vol.259 (1), p.205-215

2002

Volltextzugriff (PDF)

The BCL11A transcription factor: its distribution in normal and malignant tissues and use as a marker for plasmacytoid dendritic cells

Leukemia, 2006-08, Vol.20 (8), p.1439-1441

2006

Volltextzugriff (PDF)

Coxsackie B and adenovirus receptor, integrin and major histocompatibility complex class 1 expression in human prostate cancer cell lines: implications for gene therapy strategies

Prostate cancer and prostatic diseases, 2003-06, Vol.6 (2), p.198-198

2003

Volltextzugriff (PDF)

Erratum: Coxsackie B and adenovirus receptor, integrin and major histocompatibility complex class 1 expression in human prostate cancer cell lines: implications for gene therapy strategies

Prostate cancer and prostatic diseases, 2003-06, Vol.6 (2), p.198-198

2003

Volltextzugriff (PDF)

Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages--strategies for data mining in support of therapeutic studies

BMC genomics, 2014-05, Vol.15 (1), p.393-393

2014

Volltextzugriff (PDF)

Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC

International journal of cancer, 2010-12, Vol.127 (11), p.2510-2519

2010

Volltextzugriff (PDF)

A copper chelate of thiosemicarbazone NSC 689534 induces oxidative/ER stress and inhibits tumor growth in vitro and in vivo

Free radical biology & medicine, 2011-01, Vol.50 (1), p.110-121

2011

Volltextzugriff (PDF)

The “survivin suppressants” NSC 80467 and YM155 induce a DNA damage response

Cancer chemotherapy and pharmacology, 2012-07, Vol.70 (1), p.207-212

2012

Volltextzugriff (PDF)

Artemisinin dimer anticancer activity correlates with heme‐catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction

International journal of cancer, 2009-09, Vol.125 (6), p.1266-1275

2009

Volltextzugriff (PDF)

ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC

BMC cancer, 2009-02, Vol.9 (1), p.63-63, Article 63

2009

Volltextzugriff (PDF)

Challenges in plasma membrane phosphoproteomics

Expert review of proteomics, 2011-08, Vol.8 (4), p.483-494

2011

Volltextzugriff (PDF)

Proteomic Analysis Identifies Oxidative Stress Induction by Adaphostin

Clinical cancer research, 2007-06, Vol.13 (12), p.3667-3681

2007

Volltextzugriff (PDF)

Abstract 3916: Patient-derived organoid and cell culture models from the NCI Patient-Derived Models Repository (NCI PDMR) preserve genomic stability and heterogeneity of patient tumor specimens

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3916-3916

2020

Volltextzugriff (PDF)

Proteomic Analysis of Nuclei Isolated from Cancer Cell Lines Treated with Indenoisoquinoline NSC 724998, a Novel Topoisomerase I Inhibitor

Journal of proteome research, 2010-08, Vol.9 (8), p.4016-4027

2010

Volltextzugriff (PDF)

Abstract 5139: Cell sorting strategies for the isolation of cancer cells and associated fibroblasts from tumor biopsies, surgical resections, and patient-derived xenografts

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.5139-5139

2015

Volltextzugriff (PDF)

Abstract 4827: Establishing a platform for the generation of organoids from diverse tumor types as part of the NCI patient-derived models (PDM) initiave

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4827-4827

2017

Volltextzugriff (PDF)

Abstract 6914: Genomic landscape and stability of preclinical models in NCI's patient-derived models repository

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.6914-6914

2024

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(49)
Reviews
(4)

Sprache

Englisch
(53)

Erscheinungsjahr

n.n

Thema

Humans
(26)
Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Animals
(13)
Oncology
(11)
Biological And Medical Sciences
(10)
Cell Line, Tumor
(10)
Biochemistry & Molecular Biology
(9)
Medical Sciences
(8)
Mice
(7)
Antineoplastic Agents - Pharmacology
(6)
Cancer
(6)
Tumors
(6)
Biochemical Research Methods
(5)
Blotting, Western
(5)
Female
(5)
Gene Expression Profiling
(5)
Immunohistochemistry
(5)
Antibody
(4)
Apoptosis - Drug Effects
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antibodies as therapeutic agents: vive la renaissance

An enthesitis based model for the pathogenesis of spondyloarthropathy. additive effects of microbial adjuvant and biomechanical factors at disease sites

The role of therapeutic antibodies in drug discovery

Dendritic cells: Immunological sentinels with a central role in health and disease

The BCL11AXL transcription factor: its distribution in normal and malignant tissues and use as a marker for plasmacytoid dendritic cells

CD70 (TNFSF7) is expressed at high prevalence in renal cell carcinomas and is rapidly internalised on antibody binding

Coxsackie and adenovirus receptor (CAR)-dependent and major histocompatibility complex (MHC) class I-independent uptake of recombinant adenoviruses into human tumour cells

Coxsackie B and adenovirus receptor, integrin and major histocompatibility complex class I expression in human prostate cancer cell lines: implications for gene therapy strategies

Engineered expression of the Coxsackie B and adenovirus receptor (CAR) in human dendritic cells enhances recombinant adenovirus-mediated gene transfer

The BCL11A transcription factor: its distribution in normal and malignant tissues and use as a marker for plasmacytoid dendritic cells

Coxsackie B and adenovirus receptor, integrin and major histocompatibility complex class 1 expression in human prostate cancer cell lines: implications for gene therapy strategies

Erratum: Coxsackie B and adenovirus receptor, integrin and major histocompatibility complex class 1 expression in human prostate cancer cell lines: implications for gene therapy strategies

Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages--strategies for data mining in support of therapeutic studies

Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC

A copper chelate of thiosemicarbazone NSC 689534 induces oxidative/ER stress and inhibits tumor growth in vitro and in vivo

The “survivin suppressants” NSC 80467 and YM155 induce a DNA damage response

Artemisinin dimer anticancer activity correlates with heme‐catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction

ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC

Challenges in plasma membrane phosphoproteomics

Proteomic Analysis Identifies Oxidative Stress Induction by Adaphostin

Abstract 3916: Patient-derived organoid and cell culture models from the NCI Patient-Derived Models Repository (NCI PDMR) preserve genomic stability and heterogeneity of patient tumor specimens

Proteomic Analysis of Nuclei Isolated from Cancer Cell Lines Treated with Indenoisoquinoline NSC 724998, a Novel Topoisomerase I Inhibitor

Abstract 5139: Cell sorting strategies for the isolation of cancer cells and associated fibroblasts from tumor biopsies, surgical resections, and patient-derived xenografts

Abstract 4827: Establishing a platform for the generation of organoids from diverse tumor types as part of the NCI patient-derived models (PDM) initiave

Abstract 6914: Genomic landscape and stability of preclinical models in NCI's patient-derived models repository

Suchergebnisse filtern